RIPE-KG · Version 1.1.0 · Resource
ripekg:work/RIPEW92CD9934BA894E47
https://w3id.org/ripe/ripe-kg/work/RIPEW92CD9934BA894E47
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1136%2Fbmj-2024-081557Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW92CD9934BA894E47Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
ripekg:work/RIPEW92CD9934BA894E47Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
dcterms:title |
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
ripekg:work/RIPEW92CD9934BA894E47Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
rdf:type |
node1 |
ripekg:work/RIPEW92CD9934BA894E47Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/RIPEW92CD9934BA894E47Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
rdf:type |
rdfs:Resource |
ripekg:work/RIPEW92CD9934BA894E47Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
rdf:type |
owl:Thing |
ripekg:work/RIPEW92CD9934BA894E47Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
rdf:type |
prov:Entity |
ripekg:work/RIPEW92CD9934BA894E47Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial |
rdf:type |
ripe:WorkWork |